Delivery Order SPE2DB24D2101-SPE2DB25FKPSR
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $25,366.11 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xifaxan is a non-systemic antibiotic used primarily in the treatment of traveler's...
- The Defense Logistics Agency awarded a $14.9K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a non-absorbed antibiotic commonly used in federal medical supply chains to support...
- The Defense Logistics Agency awarded a $9,260.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Xifaxan 550 mg tablets, with an ultimate completion date of August 18, 2025. This non-set-aside delivery order was competitively awarded on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a non-absorbed antibiotic commonly used in military and federal healthcare settings for...
- The Defense Logistics Agency awarded a delivery order valued at $6,348.06 to AmerisourceBergen Drug Corp for 60-tablet bottles of Xifaxan 550 mg on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xifaxan is an antibiotic used to treat traveler's diarrhea and other gastrointestinal conditions, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $7,597.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for ultimate completion on August 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $43,495.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). The contract, which represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, carries an ultimate completion date of September 4, 2025, and involves no set-aside designation, indicating competitive award status. Performance will be executed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a contract value of $4,557.98. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,215.61 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award involved no set-aside designation, indicating it was competitively awarded through open competition. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) with a ceiling value of $9,579.60. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) valued at $2,759.13. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents performance at the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued...